Adult patients taking Wegovy saw a reduced risk of experiencing a major adverse cardiovascular event within the first three months of treatment, according to a secondary analysis of the drug’s ...

(Reuters) -The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its weight-loss drug Wegovy and will decide in the fourth quarter ...

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on ...

For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors. Though listed on American stock ...

More accurate prediction of heart disease: A new study found that a blood test that specifically looks at lipoproteins associated with “bad cholesterol” could be a more accurate predictor of h ...

The health benefits of a fruit have been highlighted with experts saying they can reduce the risk of heart disease, stroke, diabetes and high cholesterol. This advice was shared on the Fast 800 ...

The move is part of a new partnership between Caremark and Wegovy's manufacturer, Novo Nordisk, according to CVS' first-quarter earnings release. Caremark will also drop the weight loss drug ...

One particular island in Japan could hold the secret diet that has been shown to improve longevity and reduce the risk of heart disease. The prefecture of Okinawa is classified as one of the world ...

Children with low vitamin D levels face a greater risk of early heart disease, according to a decades-long Finnish study. Could early supplementation shift the tide on cardiovascular prevention?

New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease ... are also on the rise. Novo Nordisk, the company that makes ...

Information About Us Contact us Feedback Terms Of Service Privacy Policy Subscriber Agreement JPost Jobs Cancel Subscription Sitemap Customer Service JP Store ...

Shares of Hims & Hers closed up 23% on Tuesday, while Novo Nordisk's stock closed up 4%. The Danish drugmaker is racing to capture more patients now that many compounding pharmacies are legally ...